Eric Venker

Companies

• Immunovant, Inc.Chief executive officer Jul 30, 2025 to now¹
• RoivantChief executive officer Jul 23, 2025 to now²
• RoivantChief operating officer Oct 1, 2021 to now³
• Immunovant, Inc.Board member Feb 19, 2020 to now⁴
• RoivantPresident Oct 1, 2021 to Jul 29, 2025³
• Arbutus BiopharmaBoard member Feb 19, 2020 to Feb 19, 2020⁵
• Sio Gene Therapies Inc.Board member Feb 19, 2020 to Feb 19, 2020⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Roivant ROIV1,599,154 shares⁷$54.4M at $34.00Aug 28, 2026
• IImmunovant, Inc. IMVT254,280 shares⁸$7.0M at $27.51Jul 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 28, 2026Sold 33,818 shares at $36.44 of Roivant⁷
• Aug 28, 2026Sold 166,182 shares at $35.63 of Roivant⁷
• Aug 28, 2026Exercised options 200,000 shares at $3.85 of Roivant⁷
• Aug 20, 2026Shares withheld for tax 13,909 shares at $36.84 of Roivant⁹
• Jul 27, 2026Sold 200,000 shares at $34.95 of Roivant¹⁰
• Jul 27, 2026Exercised options 200,000 shares at $3.85 of Roivant¹⁰
• Jul 2, 2026Sold 3,092 shares at $38.48 of Immunovant, Inc.⁸
• Jul 1, 2026Returned to company 86,629 shares at $38.14 of Immunovant, Inc.⁸
• Jul 1, 2026Exercised options 92,188 shares at $14.46 of Immunovant, Inc.⁸
• Jun 24, 2026Sold 46,234 shares at $33.51 of Roivant¹¹
• Jun 24, 2026Sold 153,766 shares at $33.05 of Roivant¹¹
• Jun 24, 2026Exercised options 200,000 shares at $3.85 of Roivant¹¹
• May 22, 2026Sold 200,000 shares at $30.27 of Roivant¹²
• May 22, 2026Exercised options 200,000 shares at $3.85 of Roivant¹²
• May 20, 2026Shares withheld for tax 34,483 shares at $32.41 of Roivant¹²
• Apr 20, 2026Sold 200,000 shares at $29.59 of Roivant¹³
• Apr 20, 2026Exercised options 200,000 shares at $3.85 of Roivant¹³
• Apr 7, 2026Granted 232,252 shares of Immunovant, Inc.¹⁴
• Apr 2, 2026Sold 1,409 shares at $24.60 of Immunovant, Inc.¹⁵
• Apr 2, 2026Sold 12,820 shares at $24.04 of Immunovant, Inc.¹⁵
• Apr 1, 2026Returned to company 334,960 shares at $25.10 of Immunovant, Inc.¹⁵
• Apr 1, 2026Exercised options 368,750 shares at $14.46 of Immunovant, Inc.¹⁵
• Mar 17, 2026Sold 200,000 shares at $28.24 of Roivant¹⁶
• Mar 17, 2026Exercised options 200,000 shares at $3.85 of Roivant¹⁶
• Feb 20, 2026Shares withheld for tax 7,051 shares at $27.15 of Roivant¹⁷